Kit Check Raises $12 Million Series B

Kit Check™ (, the leader in hospital pharmacy kit processing and medication tracking software, today announced a $12 million Series B funding round led by Kaiser Permanente Ventures. Rex Health Ventures, the venture investment arm of Raleigh, N.C.-based Rex Healthcare, also contributed to the round. All previous investors from the 2013 Series A funding round also participated in the Series B; these include New Leaf Venture Partners, Sands Capital Ventures, Easton Capital Investment Group and LionBird. Dave Schulte, vice president and senior managing director of Kaiser Permanente Ventures, will also join Kit Check’s Board of Directors.